当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析

欧林生物

(688319)

  

流通市值:26.23亿  总市值:36.96亿
流通股本:2.88亿   总股本:4.06亿

欧林生物(688319)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.27亿元,每股收益-0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益90769.11万元,未分配利润-12165.01万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产159413.73万元,负债68644.62万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入70,798,700.81496,118,667.03352,299,329.93233,199,414.85
营业总成本109,128,006.76490,851,002.62328,847,307.58196,436,358.93
营业利润-28,310,589.673,098,409.3520,095,123.4722,267,603.3
利润总额-27,295,829.8215,616,461.8129,876,177.8231,248,503.3
净利润-27,295,829.8211,441,126.6926,052,088.2426,444,706.03
其他综合收益----
综合收益总额-27,295,829.8211,441,126.6926,052,088.2426,444,706.03
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计884,224,118.91931,189,753.59925,755,174.12912,416,806.36
非流动资产合计709,913,157.08681,416,011.5580,820,672.45569,681,282.02
资产总计1,594,137,275.991,612,605,765.091,506,575,846.571,482,098,088.38
流动负债合计421,257,119.53476,219,328.52408,294,669.77449,822,682.95
非流动负债合计265,189,054.58205,620,900.19157,590,700.94108,856,997.5
负债合计686,446,174.11681,840,228.71565,885,370.71558,679,680.45
归属于母公司股东权益合计895,130,016.8916,905,551.64924,619,836.26911,986,284.5
股东权益合计907,691,101.88930,765,536.38940,690,475.86923,418,407.93
负债和股东权益合计1,594,137,275.991,612,605,765.091,506,575,846.571,482,098,088.38
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计91,177,236.11531,328,281.52381,748,636.02234,839,939.47
经营活动现金流出小计156,571,598.54487,327,506.72392,184,721.9255,811,223.55
经营活动产生的现金流量净额-65,394,362.4344,000,774.8-10,436,085.88-20,971,284.08
投资活动现金流入小计10,018,657.53151,041,729.01146,017,632.8890,644,728.77
投资活动现金流出小计77,328,580.1229,884,820.44122,620,764.78109,917,251.61
投资活动产生的现金流量净额-67,309,922.57-78,843,091.4323,396,868.1-19,272,522.84
筹资活动现金流入小计67,773,800235,314,605.4158,390,805.495,919,424
筹资活动现金流出小计3,820,739.95106,047,945.688,727,895.1352,024,251.05
筹资活动产生的现金流量净额63,953,060.05129,266,659.869,662,910.2743,895,172.95
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-68,751,224.9594,424,343.1782,623,692.493,651,366.03
期末现金及现金等价物余额286,783,648.23355,534,873.18343,734,222.5264,761,896.04
最新报告期:2024-04-26
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西南证券杜向阳0.190.310.482024-04-26
TOP↑